pre-ipo
Stage
1
Investors
About
Biohaven is a clinical-stage biopharmaceutical company developing treatments for diseases in immunology, neuroscience, oncology, and obesity, including migraine therapies and novel precision immunology drugs.
Explore Biohaven's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.